(Finance) – Day to forget for Campari which in Milan closed the last session of the week by recording a -5.21% to 5,782 euros per share. The company is discounting the publication in the United States of a report by White House public health advisor Dr Vivek Murthywhich highlighted the need to indicate on the labels of alcoholic products i cancer risks related to their hiring. Murthy then suggested a change in regulations and greater public awareness.
In the report, the “Surgeon General” of the White House underlined that alcohol consumption in States United it is “the third leading cause of cancer, after tobacco and obesity”. The study, in particular, estimated that in 2019 approximately 96,730 cases of cancer were related to alcohol consumption and underlined that “in women, alcohol consumption is correlated with breast cancer, with an estimate of 44,180 cases in 2019 , accounting for 16.4% of the approximately 270,000 total cases of breast cancer among women.”
TO level global the study estimated that there were 741,300 cases of cancer related to alcohol consumption in 2020, of which 185,100 resulted from consumption of approximately two drinks a day or less.
Like Campari, other titles of the alcohol sector have seen the price drop significantly today: among these we highlight Remy Cointreau (-5%), Pernod Ricard (-3.1%), Diageo (-3.7%) e AB InBev (-2.3%)